Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index ...

The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...

Mirikizumab is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to the p19 subunit of human interleukin (IL)-23.

17,000 people answered the IBD UK Patient Survey, and the results reveal patients are facing long waits at every stage of the ...

Jane Searfoss was inspired to become a child life specialist at Boston Children's Hospital because of her own experience ...

Treating Newly-Diagnosed Crohn's Patients With Advanced ... have the skin condition, and children ... Developing a Less Invasive Test for Inflammatory Bowel Disease Sep. 7, 2023 — Millions ...

Around 40,000 children in the United States suffer from Crohn's disease. Among those patients, around 1 in 3 will develop perianal fistulas. Perianal fistulas are tunnels that develop near the anus.

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease. A new study published recently in the journal Gut shows children with Crohn's ...

"Our study suggests that vedolizumab is a viable option for induction and long-term maintenance therapy in children with IBD, ...

Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...